You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 132 No. 1, January 1997 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Characteristics of Thoracic Duct Lymph in Multiple Organ Dysfunction Syndrome

Miguel Sánchez-García, MD, PhD; Alfredo Prieto, PhD; Alberto Tejedor, MD, PhD; Antonio Martin-Duce, MD, PhD; F. Javier Fernandez-Sánchez, PharmD; Javier Granell, MD; Melchor Alvarez-Mon, MD, PhD

Arch Surg. 1997;132(1):13-18.


Abstract



Objective
To investigate the presence of endotoxin, bacteria, and potential humoral and cellular mediators in thoracic duct lymph and peripheral blood in patients with severe refractory multiple organ dysfunction.

Design
Convenience sample.

Setting
General intensive care unit of a university hospital.

Patients
Two men and 2 women were studied after a mean of 7.25 days (range, 6-9 days) of multiple organ dysfunction syndrome. The primary injury was thoracic in 1 patient and abdominal in 3 patients.

Intervention
The thoracic duct was cannulated with a 7F catheter and samples of lymph and peripheral blood were obtained.

Main Outcome Measures
Simultaneous lymph and serum levels of lipopolysaccharide, tumor necrosis factor {alpha}, interleukin-1β, and interleukin-6, and activation markers on T lymphocytes.

Results
Lipopolysaccharide and cytokine levels were low in lymph and serum, except for a mean lymph-to-serum ratio of 53.4 for interleukin-1β. There was phenotypical evidence of intense polyclonal T-lymphocyte activation in both lymph and peripheral blood with increased lymph-to-peripheral blood ratios. Increased percentages in lymph of CD45RA+CD45RO+ lymphocytes were observed. In 1 patient, Proteus mirabilis grew simultaneously in lymph, pancreatic necrosis fluid, and a central venous catheter tip. All simultaneous blood cultures were negative.

Conclusions
Our results provide evidence of the participation of the gut-associated lymphatic tissue in the pathogenesis of the multiple organ dysfunction syndrome, suggesting that T-cell activation and cytokine production occur at the gut level. Future studies are needed to confirm and extend our findings.

Arch Surg. 1997;132:13-18



Author Affiliations



From the Intensive Care Unit and Department of Surgery, Hospital Universitario Príncipe de Asturias, Alcalá de Henares (Drs Sánchez-García, Martin-Duce, and Granell); Department of Medicine, University of Alcalá de Henares, Alcalá de Henares (Drs Prieto and Alvarez-Mon); Department of Nephrology, Hospital Gregorio Marañón, (Dr Tejedor); and Department of Microbiology, Hospital Ramón y Cajal (Dr Fernandez-Sánchez), Madrid, Spain.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Disorders of the lymph circulation: their relevance to anaesthesia and intensive care
Mallick and Bodenham
Br J Anaesth 2003;91:265-272.
ABSTRACT | FULL TEXT  

Compartments That Cause the Real Damage in Severe Acute Pancreatitis
Neoptolemos
Am. J. Respir. Crit. Care Med. 2003;168:141-142.
FULL TEXT  

Human thoracic duct lymph inhibits lipopolysaccharide-induced release of cytokines
Lemaire et al.
Innate Immunity 1997;4:331-338.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.